KTTA - Pasithea Therapeutics Corp. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
0.74 0.0 (-0.16%)	---	---	---	-0.01 (-2.02%)	0.02 (2.55%)	0.0 (0.0%)	0.0 (0.0%)

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.66
Diluted EPS:: -0.66
Basic P/E:: -1.1132
Diluted P/E:: -1.1132
RSI(14) 1m:: 100.0
VWAP:: 0.73
RVol:: 1.6877

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	0.73 +0.01 (+1.15%)	Oct 15 15:38
1m	Price increase 1m	0.73 +0.01 (+1.17%)	Oct 15 12:49
1m	Price increase 1m	0.73 +0.01 (+1.8%)	Oct 15 12:28
1m	Price increase 1m	0.73 +0.03 (+4.29%)	Oct 15 10:27
1m	Price increase 1m	0.73 +0.03 (+4.7%)	Oct 15 10:26